DAIC

FEBRUARY 10, 2025

6, 2025 Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung diseases, recently announcedpublication of a peer-reviewed study evaluating its novel algorithm for the detection of pulmonary hypertension (PH). tim.hodson Mon, 02/10/2025 - 12:43 Feb.

Research 64

Research Innovation Pulmonary Hypertension 64

DAIC

FEBRUARY 2, 2024

As Biosense Webster advances innovation for the treatment of AFib, we are thinking not only about new modalities of ablation, such as pulsed field ablation, but also how to make procedures safer, more effective and efficient. 1 Among 208 patients included in the Real AF Registry cohort, a total of three PAEs were reported.1

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

DAIC

DECEMBER 22, 2023

SmartPulse is a prospective, single arm, multi-center, clinical evaluation that will enroll approximately 250 patients with paroxysmal AFib in the United States to evaluate the safety and effectiveness of the Dual Energy STSF Catheter. “ The SmartPulse pivotal trial will allow us to learn more about the promise of PFA in paroxysmal AFib.

Atrial Fibrillation 59

Atrial Fibrillation AFIB Ablation Heart Rhythm 59

DAIC

JULY 29, 2024

mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth.

Innovation 105

Innovation Aortic valve Aortic CMS 105

DAIC

JULY 24, 2024

Mohr-Durdez added, “To help enhance patient care in this field, Volta Medical aims to further integrate its AI solution with EP innovators to help increase compatibility and address the challenges clinicians face in analyzing cardiac electrical signals.”

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

FEBRUARY 24, 2025

By enabling the decisive shift from a reactive to a proactive cardiology model, this technology doesnt just improve patient outcomes it is also helping keep cardiovascular care sustainable and affordable. Most powerfully, it does so without requiring more in-office visits, surgical interventions and hospital stays.

Hospital 52

Hospital Cardiovascular Disease Heart Failure Heart Attack 52

DAIC

JUNE 24, 2024

Food and Drug Administration ( FDA ) of the company's Cordella Pulmonary Artery (PA) Sensor System for the treatment of New York Heart Failure (NYHA) class III heart failure patients. Secure messaging on a tablet between the clinical team, patient, and caregiver to support remote care.

Heart Failure 109

Heart Failure Reimbursement Heart Transplant Pulmonary 109